Homayon Ghiasi Selected Research

Homayon Ghiasi Research Topics

Disease

35	Infections 10/2022 - 10/2002
13	Eye Infections 01/2022 - 09/2002
13	Cicatrix (Scar) 01/2018 - 06/2002
12	Eye Diseases (Eye Disease) 11/2022 - 10/2002
10	Demyelinating Diseases (Demyelinating Disease) 01/2023 - 05/2005
4	Latent Infection 10/2022 - 01/2018
4	Herpetic Keratitis 12/2017 - 03/2005
4	Blepharitis 01/2010 - 02/2004
3	Virus Diseases (Viral Diseases) 11/2013 - 11/2005
2	Dermatitis 01/2018 - 09/2007
1	Reinfection 10/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Glioblastoma (Glioblastoma Multiforme) 03/2014
1	Brain Neoplasms (Brain Tumor) 03/2014
1	Melanoma (Melanoma, Malignant) 03/2014
1	Neoplasms (Cancer) 03/2014
1	Optic Nerve Diseases (Optic Neuropathy) 11/2013
1	Limbal Stem Cell Deficiency 01/2013
1	Multiple Sclerosis 02/2011
1	Vision Disorders (Hemeralopia) 07/2009
1	Optic Neuritis (Retrobulbar Neuritis) 07/2009
1	Keratitis 05/2007
1	Coinfection 09/2002

Drug/Important Bio-Agent (IBA)

13	Interleukin-2 (IL2)IBA 01/2023 - 06/2002
12	Glycoproteins (Glycoprotein)IBA 10/2022 - 05/2007
10	VaccinesIBA 10/2022 - 02/2004
8	Interleukin-4 (Interleukin 4)IBA 11/2022 - 06/2002
8	CytokinesIBA 01/2021 - 06/2002
8	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 02/2004
5	Interferon-gamma (Interferon, gamma)IBA 11/2022 - 10/2002
5	Interleukin-12 Subunit p35IBA 05/2017 - 06/2002
5	Interleukin-12 Subunit p40IBA 05/2017 - 06/2002
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2013
4	Interleukin-12 (IL 12)IBA 05/2017 - 12/2002
3	Messenger RNA (mRNA)IBA 10/2022 - 12/2002
3	Member 14 Tumor Necrosis Factor ReceptorsIBA 01/2019 - 04/2014
2	Interleukin-6 (Interleukin 6)IBA 01/2023 - 01/2019
2	Interleukin-10 (Interleukin 10)IBA 01/2023 - 01/2021
2	Interleukin-17 (Interleukin 17)IBA 01/2023 - 01/2021
2	Peptides (Polypeptides)IBA 01/2021 - 11/2013
2	Interleukin-9 (Interleukin 9)IBA 01/2021 - 01/2019
2	InterleukinsIBA 01/2019 - 04/2011
2	Macrophage Colony-Stimulating FactorIBA 01/2018 - 01/2017
2	Immunoglobulins (Immunoglobulin)IBA 04/2014 - 01/2010
2	DNA VaccinesIBA 11/2005 - 02/2004
2	Neutralizing AntibodiesIBA 02/2004 - 10/2002
1	Interleukin-17 ReceptorsIBA 01/2023
1	signal peptide peptidaseIBA 10/2022
1	Small Untranslated RNAIBA 01/2022
1	RNA IIBA 01/2022
1	Interferon-betaIBA 01/2022
1	Chemokine CCL5IBA 01/2019
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2019
1	Interferon Type IIBA 01/2019
1	LigandsIBA 01/2019
1	Lymphotoxin-alpha (Lymphotoxin)IBA 01/2019
1	RoscovitineIBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	PlasticsIBA 01/2018
1	ChemokinesIBA 01/2017
1	Viral DNAIBA 10/2016
1	Protein Sorting Signals (Signal Peptide)IBA 03/2015
1	3- di- (N- carboxybenzoyl- leucyl- leucyl)amino acetone 1IBA 06/2014
1	NectinsIBA 04/2014
1	Sulfates (Sulfates, Inorganic)IBA 04/2014
1	Heparin (Liquaemin)FDA LinkGeneric 04/2014
1	simplexvirus receptorIBA 04/2014
1	Thymidine KinaseIBA 03/2014
1	Temozolomide (Temodar)FDA LinkGeneric 03/2014
1	EnzymesIBA 03/2014
1	Ganciclovir (Cytovene)FDA LinkGeneric 03/2014
1	CD40 Ligand (CD40L)IBA 03/2010
1	Immunoglobulin IsotypesIBA 01/2010
1	Immunoglobulin G (IgG)IBA 01/2010
1	Luxol Fast Blue MBS (Luxol fast blue)IBA 07/2009
1	Ophthalmic Solutions (Eye Drops)IBA 06/2009
1	Granzymes (Granzyme)IBA 06/2009
1	AntibodiesIBA 05/2007
1	Viral VaccinesIBA 11/2005

Therapy/Procedure

1	Injections 11/2022
1	Drug Therapy (Chemotherapy) 03/2014
1	Immunotherapy 03/2014
1	Transplantation 01/2013